Hemogenyx Pharmaceuticals (LSE:HEMO) FCF Margin %: 0.00% (As of Dec. 2025)


LSE:HEMO Hemogenyx Pharmaceuticals PLC LSE:HEMO
31 GF Score
Price £7.80
! 2 Warning Signs
View Full Analysis

What is Hemogenyx Pharmaceuticals FCF Margin %?

Hemogenyx Pharmaceuticals LSE:HEMO +5.55% 31 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates LSE:HEMO with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 957 Biotechnology companies, Hemogenyx Pharmaceuticals ranks worse than 104493.1% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hemogenyx Pharmaceuticals's Free Cash Flow for the six months ended in Dec. 2025 was £0.34 Mil. Hemogenyx Pharmaceuticals's Revenue for the six months ended in Dec. 2025 was £0.00 Mil. Therefore, Hemogenyx Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Hemogenyx Pharmaceuticals's current FCF Yield % is -6.51%.

The historical rank and industry rank for Hemogenyx Pharmaceuticals's FCF Margin % or its related term are showing as below:


LSE:HEMO's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Hemogenyx Pharmaceuticals FCF Margin % Related Terms

Hemogenyx Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Hemogenyx Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemogenyx Pharmaceuticals FCF Margin % Chart

Hemogenyx Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hemogenyx Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LSE:HEMO vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Hemogenyx Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemogenyx Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemogenyx Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hemogenyx Pharmaceuticals's FCF Margin % falls into.


LSE:HEMO
31GF Score
Hemogenyx Pharmaceuticals PLC LSE:HEMO
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemogenyx Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hemogenyx Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.452/0
= %

Hemogenyx Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.335/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Hemogenyx Pharmaceuticals (LSE:HEMO) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hemogenyx Pharmaceuticals and its competitors. According to the industry distribution chart, Hemogenyx Pharmaceuticals ranks #999999 out of 957 companies in the Biotechnology industry.
Is Hemogenyx Pharmaceuticals' FCF Margin % too high?
Hemogenyx Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, Hemogenyx Pharmaceuticals ranks #999999 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hemogenyx Pharmaceuticals has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Hemogenyx Pharmaceuticals' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hemogenyx Pharmaceuticals ranks #999999 out of 957 companies for FCF Margin %. This places Hemogenyx Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hemogenyx Pharmaceuticals and its competitors. Hemogenyx Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemogenyx Pharmaceuticals stock overvalued right now?
Hemogenyx Pharmaceuticals (LSE:HEMO) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Hemogenyx Pharmaceuticals' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hemogenyx Pharmaceuticals (LSE:HEMO), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemogenyx Pharmaceuticals Business Description

Address 6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments. The Group has one reportable segment, the discovery, development, and commercialisation of treatments relating to blood and immune system disorders and viral infections, and administrative functions in the United Kingdom. It has its presence in United Kingdom; and United States.
31GF Score

Get the complete analysis for LSE:HEMO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£7.80
Price